Product NDC: | 63851-501 |
Proprietary Name: | RabAvert |
Non Proprietary Name: | Rabies Vaccine |
Active Ingredient(s): | & nbsp; Rabies Vaccine |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63851-501 |
Labeler Name: | Novartis Vaccines and Diagnostics GmbH |
Product Type: | VACCINE |
FDA Application Number: | BLA103334 |
Marketing Category: | BLA |
Start Marketing Date: | 19971020 |
Package NDC: | 63851-501-01 |
Package Description: | 1 KIT in 1 CARTON (63851-501-01) * 1 mL in 1 VIAL, GLASS (63851-511-11) * 1 mL in 1 VIAL, GLASS (63833-765-30) |
NDC Code | 63851-501-01 |
Proprietary Name | RabAvert |
Package Description | 1 KIT in 1 CARTON (63851-501-01) * 1 mL in 1 VIAL, GLASS (63851-511-11) * 1 mL in 1 VIAL, GLASS (63833-765-30) |
Product NDC | 63851-501 |
Product Type Name | VACCINE |
Non Proprietary Name | Rabies Vaccine |
Dosage Form Name | KIT |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 19971020 |
Marketing Category Name | BLA |
Labeler Name | Novartis Vaccines and Diagnostics GmbH |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |